108 related articles for article (PubMed ID: 27966456)
1. Ablating all three retinoblastoma family members in mouse lung leads to neuroendocrine tumor formation.
Lázaro S; Pérez-Crespo M; Enguita AB; Hernández P; Martínez-Palacio J; Oteo M; Sage J; Paramio JM; Santos M
Oncotarget; 2017 Jan; 8(3):4373-4386. PubMed ID: 27966456
[TBL] [Abstract][Full Text] [Related]
2. The retinoblastoma protein is required for Ras-induced oncogenic transformation.
Williams JP; Stewart T; Li B; Mulloy R; Dimova D; Classon M
Mol Cell Biol; 2006 Feb; 26(4):1170-82. PubMed ID: 16449633
[TBL] [Abstract][Full Text] [Related]
3. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization.
Sage J; Mulligan GJ; Attardi LD; Miller A; Chen S; Williams B; Theodorou E; Jacks T
Genes Dev; 2000 Dec; 14(23):3037-50. PubMed ID: 11114892
[TBL] [Abstract][Full Text] [Related]
4. Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling.
van Harn T; Foijer F; van Vugt M; Banerjee R; Yang F; Oostra A; Joenje H; te Riele H
Genes Dev; 2010 Jul; 24(13):1377-88. PubMed ID: 20551164
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-mediated modeling and functional validation of candidate tumor suppressor genes in small cell lung cancer.
Ng SR; Rideout WM; Akama-Garren EH; Bhutkar A; Mercer KL; Schenkel JM; Bronson RT; Jacks T
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):513-521. PubMed ID: 31871154
[TBL] [Abstract][Full Text] [Related]
6. Murine bilateral retinoblastoma exhibiting rapid-onset, metastatic progression and N-myc gene amplification.
MacPherson D; Conkrite K; Tam M; Mukai S; Mu D; Jacks T
EMBO J; 2007 Feb; 26(3):784-94. PubMed ID: 17235288
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma family proteins: insights gained through genetic manipulation of mice.
Wikenheiser-Brokamp KA
Cell Mol Life Sci; 2006 Apr; 63(7-8):767-80. PubMed ID: 16465443
[TBL] [Abstract][Full Text] [Related]
8. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance.
Ku SY; Rosario S; Wang Y; Mu P; Seshadri M; Goodrich ZW; Goodrich MM; Labbé DP; Gomez EC; Wang J; Long HW; Xu B; Brown M; Loda M; Sawyers CL; Ellis L; Goodrich DW
Science; 2017 Jan; 355(6320):78-83. PubMed ID: 28059767
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.
Song Y; Gilbert D; O'Sullivan TN; Yang C; Pan W; Fathalizadeh A; Lu L; Haines DC; Martin PL; Van Dyke T
PLoS One; 2013; 8(12):e80459. PubMed ID: 24312475
[TBL] [Abstract][Full Text] [Related]
10. Correction: Ablating all three retinoblastoma family members in mouse lung leads to neuroendocrine tumor formation.
Lázaro S; Pérez-Crespo M; Enguita AB; Hernández P; Martínez-Palacio J; Oteo M; Sage J; Paramio JM; Santos M
Oncotarget; 2017 Jul; 8(30):50323. PubMed ID: 28772359
[No Abstract] [Full Text] [Related]
11. P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation.
Papavassiliou KA; Sofianidi AA; Gogou VA; Anagnostopoulos N; Papavassiliou AG
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473726
[TBL] [Abstract][Full Text] [Related]
12. SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection.
Wang Q; Gümüş ZH; Colarossi C; Memeo L; Wang X; Kong CY; Boffetta P
J Thorac Oncol; 2023 Jan; 18(1):31-46. PubMed ID: 36243387
[TBL] [Abstract][Full Text] [Related]
13. Pten and p53 Loss in the Mouse Lung Causes Adenocarcinoma and Sarcomatoid Carcinoma.
Lázaro S; Lorz C; Enguita AB; Seller I; Paramio JM; Santos M
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954335
[TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma Protein Paralogs and Tumor Suppression.
Flores M; Goodrich DW
Front Genet; 2022; 13():818719. PubMed ID: 35368709
[TBL] [Abstract][Full Text] [Related]
15. Lung neuroendocrine tumors: A systematic literature review (Review).
Savu C; Melinte A; Diaconu C; Stiru O; Gherghiceanu F; Tudorica ȘDO; Dumitrașcu OC; Bratu A; Balescu I; Bacalbasa N
Exp Ther Med; 2022 Feb; 23(2):176. PubMed ID: 35069857
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine Lung Cancer Mouse Models: An Overview.
Lorz C; Oteo M; Santos M
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33375066
[TBL] [Abstract][Full Text] [Related]
17. Distinct transcriptional programs of SOX2 in different types of small cell lung cancers.
Tenjin Y; Matsuura K; Kudoh S; Usuki S; Yamada T; Matsuo A; Sato Y; Saito H; Fujino K; Wakimoto J; Ichimura T; Kohrogi H; Sakagami T; Niwa H; Ito T
Lab Invest; 2020 Dec; 100(12):1575-1588. PubMed ID: 32801334
[TBL] [Abstract][Full Text] [Related]
18. Differential development of large-cell neuroendocrine or small-cell lung carcinoma upon inactivation of 4 tumor suppressor genes.
Lázaro S; Pérez-Crespo M; Lorz C; Bernardini A; Oteo M; Enguita AB; Romero E; Hernández P; Tomás L; Morcillo MÁ; Paramio JM; Santos M
Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22300-22306. PubMed ID: 31611390
[TBL] [Abstract][Full Text] [Related]
19. Small-cell lung cancer: what we know, what we need to know and the path forward.
Gazdar AF; Bunn PA; Minna JD
Nat Rev Cancer; 2017 Dec; 17(12):725-737. PubMed ID: 29077690
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]